Patent · US Active

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

US11639380B2 · kind B2 · utility

5Cited by

38References

11Claims

0Family size

Assignee

H. LUNDBECK A/S · DK

Inventors

Roger K. Cady · Ozark, US
Jeffrey T. L. Smith · Dublin, IE
Joseph Hirman · Bothell, US
Barbara Schaeffler · Seattle, US
Lahar Mehta · Copenhagen, DK

Key dates

Filing date	Jan 8, 2020
Grant date	May 2, 2023
Priority date	—
Expiry date	Jan 8, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.